Niagen Bioscience Inc. XNAS: NAGE

Mid-range Performer

Download real time

9.90 0.14 (1.43%)

32.61% Fall from 52W High

478.6K

XNAS Volume

XNAS 29 Sep, 2025 5:30 PM (EDT)

Niagen Bioscience Inc. quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents